Shares of Aurora Cannabis (NASDAQ:ACB) are sliding in the pre-market session today after its fourth-quarter showing. Top-line declined 8% over the prior year to C$50.2 million.
Owing to impairment charges, net loss widened to C$618.8 million from a net loss of C$134 million in the year-ago period.
While the company’s medical vertical made modest gains, its consumer vertical witnessed a decline owing to a change in the market scenario during this period.
Looking ahead, the Street expects the company to post a net loss per share of $0.09 in Q1.
Read full Disclosure
